Zhong H - Search Results

1

S-1 combined with oxaliplatin as first line chemotherapy for Chinese advanced gastric cancer patients.

Liu B, Ying J, Luo C, Xu Q, Zhu L, Zhong H. Liu B, et al. Among authors: zhong h. Hepatogastroenterology. 2012 Mar-Apr;59(114):649-53. doi: 10.5754/hge11893. Hepatogastroenterology. 2012. PMID: 22328264 Clinical Trial.

2

[Effect of Supportan on nutritional status and immune function of late-staged gastric cancer patients undergoing chemotherapy].

Zhong HJ, Ying JE, Ma SL. Zhong HJ, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Sep;9(5):405-8. Zhonghua Wei Chang Wai Ke Za Zhi. 2006. PMID: 17043961 Clinical Trial. Chinese.

3

Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer.

Zhong H, Zhang Y, Ma S, Ying JE, Yang Y, Yong D, Hang X, Sun Q, Zhong B, Wang D. Zhong H, et al. Among authors: zhong b. Anticancer Drugs. 2008 Nov;19(10):1013-8. doi: 10.1097/CAD.0b013e328314b5ab. Anticancer Drugs. 2008. PMID: 18827567

4

Inhibition of matrine against gastric cancer cell line MNK45 growth and its anti-tumor mechanism.

Luo C, Zhong HJ, Zhu LM, Wu XG, Ying JE, Wang XH, Lü WX, Xu Q, Zhu YL, Huang J. Luo C, et al. Mol Biol Rep. 2012 May;39(5):5459-64. doi: 10.1007/s11033-011-1346-5. Epub 2011 Dec 30. Mol Biol Rep. 2012. PMID: 22207169

5

Prostate adenocarcinoma with negative immunohistochemical stain of prostate-specific antigen presenting with cervical mass: A case report.

Zhu L, Luo C, Wu W, Ying J, Zhong H. Zhu L, et al. Among authors: zhong h. J Res Med Sci. 2013 Sep;18(9):814-7. J Res Med Sci. 2013. PMID: 24381627 Free PMC article.

6

Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer.

Yuan M, Yang Y, Lv W, Song Z, Zhong H. Yuan M, et al. Among authors: zhong h. Oncol Lett. 2014 Jul;8(1):351-354. doi: 10.3892/ol.2014.2131. Epub 2014 May 9. Oncol Lett. 2014. PMID: 24959275 Free PMC article.

7

Efficacy and safety of bevacizumab in Chinese patients with metastatic colorectal cancer.

Zhu LM, Zhao YZ, Ju HX, Liu LY, Chen L, Liu BX, Xu Q, Luo C, Ying JE, Yang YS, Zhong HJ. Zhu LM, et al. Asian Pac J Cancer Prev. 2014;15(16):6559-64. doi: 10.7314/apjcp.2014.15.16.6559. Asian Pac J Cancer Prev. 2014. PMID: 25169487 Free article.

8

High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab.

Zhu L, Liu B, Zhao Y, Liu L, Yang C, Yang Y, Zhong H. Zhu L, et al. Among authors: zhong h. J Cancer Res Ther. 2014 Dec;10 Suppl:246-51. doi: 10.4103/0973-1482.151451. J Cancer Res Ther. 2014. PMID: 25693928 Free article.

9

The significance of multi-line chemotherapy for advanced gastric cancer: A retrospective analysis.

Yuan M, Shi Z, Wang Z, Lv W, Yang Y, Lu F, Zhao Y, Zhong H. Yuan M, et al. Among authors: zhong h. Mol Clin Oncol. 2017 Apr;6(4):606-612. doi: 10.3892/mco.2017.1163. Epub 2017 Feb 10. Mol Clin Oncol. 2017. PMID: 28413678 Free PMC article.

10

Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study.

Qin S, Li J, Bai Y, Shu Y, Li W, Yin X, Cheng Y, Sun G, Deng Y, Zhong H, Li Y, Qian X, Zhang L, Zhang J, Chen K, Kang W; HLX04-mCRC03 Investigators. Qin S, et al. Among authors: zhong h. BioDrugs. 2021 Jul;35(4):445-458. doi: 10.1007/s40259-021-00484-9. Epub 2021 May 20. BioDrugs. 2021. PMID: 34014555 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,869 results

Search Page

Filters